IndraLab

Statements

Disopyramide inhibits mutated KCNH2. 1 / 1

| 1

reach

"In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome : a pilot study."

17711440

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Disopyramide inhibits mutated KCNH2. 1 / 1

INDRA sources:

Databases

Reading